Amylyx Pharmaceuticals, Inc. Common Stock

Go to Amylyx Pharmaceuticals, Inc. Common Stock Website

$7.94

-0.02 (-0.25%)
Live
Previous Close

$7.96

Day Range

$7.855 - $7.99

Previous Day Range

$7.56 - $8.12

Market Cap

$687.7 million USD

Day Vol.

206233

Previous Day Vol.

926447

Currency

USD

Primary Exchange

Nasdaq

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching ...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Law firm investigating potential claims against Amylyx Pharmaceuticals regarding allegedly misleading statements about Relyvrio drug launch and patient demand during November 2022 to November 2023 period.

Related tickers: AMLX.

Read Full Article

Law firm investigating potential claims against Amylyx Pharmaceuticals regarding allegedly misleading statements about Relyvrio drug launch and patient demand during November 2022-2023.

Related tickers: AMLX.

Read Full Article
Trending Tickers

Please sign in to view